0001140361-22-012847.txt : 20220404 0001140361-22-012847.hdr.sgml : 20220404 20220404141702 ACCESSION NUMBER: 0001140361-22-012847 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220404 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trilogy International Partners Inc. CENTRAL INDEX KEY: 0001689382 STANDARD INDUSTRIAL CLASSIFICATION: RADIO TELEPHONE COMMUNICATIONS [4812] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55716 FILM NUMBER: 22801429 BUSINESS ADDRESS: STREET 1: 155 - 108 AVENUE NE STREET 2: SUITE 400 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: 425 458-5900 MAIL ADDRESS: STREET 1: 155 - 108 AVENUE NE STREET 2: SUITE 400 CITY: BELLEVUE STATE: WA ZIP: 98004 FORMER COMPANY: FORMER CONFORMED NAME: Alignvest Acquisition Corp DATE OF NAME CHANGE: 20161104 6-K 1 brhc10036071_6k.htm 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2022

Commission File Number: 000-55716

Trilogy International Partners Inc.
(Translation of registrant's name into English)

155 108th Ave NE, Suite 400, Bellevue, Washington 98004
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒     Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Exhibit 99.1 to this report on Form 6-K shall be deemed to be filed and incorporated by reference into the registrant’s Registration Statement on Form S-8 (File No. 333-218631 and File No. 333-251323) and Registration Statement on Form F-3 (File No. 333-259359) and to be a part of each thereof from the date on which said exhibit is filed with this report, to the extent not superseded by documents subsequently filed or furnished.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
Trilogy International Partners Inc.
 
(Registrant)
     
Date: April 4, 2022
By:
/s/ Erik Mickels
   
Erik Mickels
 
Title:
Senior Vice President and Chief Financial Officer


EX-99.1 2 brhc10036071_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

FORM 51-102F3
MATERIAL CHANGE REPORT

ITEM 1:
NAME AND ADDRESS OF COMPANY
 
Trilogy International Partners Inc. (“Trilogy” or the “Company”)
155 108th Avenue NE, Suite 400
Bellevue, Washington, 98004 USA

ITEM 2:
DATE OF MATERIAL CHANGE
 
March 28, 2022
 
ITEM 3:
NEWS RELEASE
 
A news release announcing the material change referred to in this report was issued on March 28, 2022 through ACCESSWIRE and a copy was subsequently filed on SEDAR.
 
ITEM 4:
SUMMARY OF MATERIAL CHANGE
 
On March 28, 2022, the Company announced that it entered into an agreement to transfer, for nominal consideration, its 71.5% equity interest in Nuevatel (PCS de Bolivia) S.A. (“Nuevatel”) to Balesia Technologies, Inc., a member of the Balesia Group of Companies, which collectively develop, own and operate wireless networks, IoT Edge and Multi-Edge Computing technologies, and supporting infrastructure across Latin America.
 
ITEM 5:
FULL DESCRIPTION OF MATERIAL CHANGE
 
On March 28, 2022, the Company announced that it entered into an agreement to transfer, for nominal consideration, its 71.5% equity interest in Nuevatel to Balesia Technologies, Inc., a member of the Balesia Group of Companies, which collectively develop, own and operate wireless networks, IoT Edge and Multi-Edge Computing technologies, and supporting infrastructure across Latin America.
 
The transaction is subject to customary closing conditions, and Trilogy anticipates that the closing will take place in the second quarter of 2022.
 
ITEM 6:
RELIANCE ON SUBSECTION 7.1(2) OF NATIONAL INSTRUMENT 51-102
 
Not applicable.
 
ITEM 7:
OMITTED INFORMATION
 
Not applicable.
 
ITEM 8:
EXECUTIVE OFFICER
 
For further information, please contact Ann Saxton, Investor Relations & Corporate Development, (425) 458-5900.
 
ITEM 9:
DATE OF REPORT
 
This Material Change Report is dated April 4, 2022.
 

1